Copyright
©2006 Baishideng Publishing Group Co.
World J Gastroenterol. Dec 7, 2006; 12(45): 7337-7340
Published online Dec 7, 2006. doi: 10.3748/wjg.v12.i45.7337
Published online Dec 7, 2006. doi: 10.3748/wjg.v12.i45.7337
Before vaccination | After vaccination | P | |||
Range | Median | Range | Median | ||
Patients | |||||
Total Serum Bilirubin (mg/L) | 4-210 | 7 | 3-250 | 7.5 | 9.5 |
ALT (IU/L) | 19-163 | 42 | 19-136 | 27.5 | 0.11 |
AST (IU/L) | 28-299 | 38 | 30-288 | 43 | 0.07 |
Controls | |||||
Total Serum Bilirubin (mg/L) | 3-6 | 5 | 1-6 | 4 | 4.8 |
ALT (IU/L) | 9-21 | 18 | 10-27 | 17 | 0.93 |
AST (IU/L) | 21-39 | 27 | 21-57 | 31 | 0.01b |
- Citation: El-Karaksy HM, El-Hawary MI, El-Koofy NM, El-Sayed R, El-Raziky MAS, Mansour SA, Taha GM, El-Mougy F. Safety and efficacy of hepatitis A vaccine in children with chronic liver disease. World J Gastroenterol 2006; 12(45): 7337-7340
- URL: https://www.wjgnet.com/1007-9327/full/v12/i45/7337.htm
- DOI: https://dx.doi.org/10.3748/wjg.v12.i45.7337